Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on April 8th, 2011% Researchers at the Norwegian University of Life Sciences, near Oslo, are studying and testing plant extracts that have been used in traditional African medicine to fight malaria. The team hopes the project leads to supplements and replacements for today’s conventional medicines.
Malaria is a mosquito-borne disease caused by a parasite. People with malaria often experience . . . → Read More: African Plants Tested as Malaria Therapies, Insecticides
By Alan, on April 8th, 2011% CT scan of the brain six days after acute stroke. (Institute for Neurological Research)
A study at University of Iowa in Iowa City finds stroke victims can benefit from a brief treatment of antidepressants, with physical recovery continuing many months after the medication is stopped. The results of the study appeared in a . . . → Read More: Antidepressants Aid in Long-Term Stroke Recovery
By Alan, on April 7th, 2011% Soybean field (Agricultural Research Service/USDA)
Research conducted at Iowa State University in Ames found an external gene introduced to soybeans can substantially increase the amount of protein in soybean seeds. The university has filed a patent and aims to commercialize the technology.
Professor of genetics Eve Wurtele and adjunct professor Ling Li placed . . . → Read More: Gene Added to Soybean Plants Adds Protein to Seeds
By Alan, on April 7th, 2011% (NASA.gov)
Researchers at Washington University School of Medicine in St. Louis, Missouri have found that workers exposed to welding fumes may face increased risks of damage to the same brain area harmed by Parkinson’s disease. The study appears online 6 April 2011, in the journal Neurology (paid subscription required).
Fumes produced by welding . . . → Read More: Brain Damage Potential from Welding Fumes Exposure
By Alan, on April 7th, 2011% (National Institute on Aging, NIH)
The U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). The drug was developed by Xenoport of Santa Clara, California and GlaxoSmithKline of Research Triangle Park, North Carolina.
Horizant’s compound is gabapentin enacarbil that uses the body’s nutrient . . . → Read More: FDA Approves Drug for Restless Legs Syndrome
By Alan, on April 7th, 2011% Turbine blade test in wind tunnel (Risø DTU)
Denmark’s National Laboratory for Sustainable Energy and three corporate partners have developed a controllable trailing edge for wind turbine blades that can reduce loads on turbines and help reduce the cost of electricity from wind power. The lab, known as Risø DTU, is part of . . . → Read More: Wind Turbine Blade Edge Helps Reduce Power Costs
By Alan, on April 6th, 2011% Patrick Daugherty (George Foulsham, UCSB)
Chemical engineers at University of California, Santa Barbara have created molecular probes that the developers say can lead to new drugs to treat cancer and other illnesses. Chemical engineering professor Patrick Daugherty and postdoc Abeer Jabaiah published their findings in a recent online issue of the journal Chemistry . . . → Read More: Molecular Probes Developed to Analyze Cancer Cells
By Alan, on April 6th, 2011% Students at University of Toronto in Canada have designed a smartphone application that merges a voice synthesizer with a GPS to give people who cannot speak the words they need. The app, called MyVoice, is available for the iPhone, with an Android version in development.
MyVoice is an assistive and augmentative communication device that adds . . . → Read More: Smartphone App Gives Voice to Those Who Cannot Speak
By Alan, on April 6th, 2011% (USA.gov)
Researchers at University of Maryland School of Pharmacy in Baltimore found a sharp increase in reports of adverse drug events to the Food and Drug Administration in the years 2000 through 2009, but the reasons for the jump may be more complex than the quality of the drugs. Their findings appear in . . . → Read More: FDA Adverse Drug Event Reports Jump in Past Decade
By Alan, on April 6th, 2011% (National Renewable Energy Laboratory)
The Department of Energy has awarded three sets of grants to promote development of advanced solar photovoltaic (PV)-related manufacturing processes in the U.S. The $112.5 million awards over five years are part of the department’s SunShot Initiative that aims to make large-scale solar energy systems cost competitive without subsidies . . . → Read More: Energy Dept. Funding Solar Manufacturing Development
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.